ALLISON HARVEY: Open Payments
NPI 1851601900 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 126 payments from 13 companies in 2025. Trend: 2023 $742 · 2024 $1,560 · 2025 $2,137
Food & beverage: $2,086Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $519 |
| Janssen Biotech, Inc. | 19 | $344 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $234 |
| Aimmune Therapeutics, Inc. | 11 | $198 |
| Gilead Sciences, Inc. | 10 | $170 |
| PFIZER INC. | 7 | $166 |
| Phathom Pharmaceuticals, Inc. | 9 | $134 |
| Lilly USA, LLC | 5 | $96 |
| Madrigal Pharmaceuticals | 4 | $78 |
| Celltrion USA Inc. | 4 | $71 |
Products named: TREMFYA, LINZESS, ZENPEP, ENTYVIO, VOQUEZNA, CREON, RINVOQ, OMVOH.
Industry payments across FL — which companies pay providers there.
